Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...
Blog Post
November 15, 2022
Congress has excellent legislation on the docket that would protect American citizens, yield huge returns, and create a safer, healthier world. We encourage the US Congress to urgently finance and authorize the PASTEUR Act, leveraging American ingenuity to boost our shared health future.
Blog Post
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.
Blog Post
July 20, 2022
Get ready for Pandemic Proof, a new podcast from the Center for Global Development. Hosted by CGD's Amanda Glassman and Javier Guzman and featuring guests from around the world, Pandemic Proof will confront weaknesses in the global architecture for pandemic preparedness and response, and explore pol...
Blog Post
June 28, 2022
CGD has set up a working group to examine different ways to purchase antimicrobials in LMICs in order to identify actionable policies to improve access and stewardship for key products and increase funding for research into new ones. We are launching today the Working Group’s first working paper.
Blog Post
June 06, 2022
This blog post argues that higher health spending is unlikely to be sustained because of the pandemic’s adverse impact on revenues, other spending pressures, and the resulting deteriorating fiscal position of LLMICs. This suggests that countries will need to undertake policy actions to create additi...
POLICY PAPERS
June 06, 2022
Before the pandemic, the achievement of the SDGs by 2030 was doubtful in part because of the slow pace in generating additional revenues from domestic sources. As the financing needs have increased after the pandemic, the achievement of these goals will be delayed beyond 2030, unless additional fina...